Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Bone Marrow Stem Cell Transplantation in T2DM
NCT01759823Phase 3Completed
- Sponsor
- Post Graduate Institute of Medical Education and Research
- Start
- Dec 2012
- Primary completion
- Dec 2014
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 3 trial of autologous bone marrow derived mesenchymal stromal cells, autologous bone marrow-derived mononuclear cell in type 2 diabetes mellitus (T2DM), sponsored by Post Graduate Institute of Medical Education and Research. Started Dec 2012; status: completed.
02
Drugs
autologous bone marrow derived mesenchymal stromal cellsautologous bone marrow-derived mononuclear cell
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01759823.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01759823.